XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Parent
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Deferred Compensation Employee Stock Trust, Net
Employee Stock Trust
Noncontrolling Interest
Total
Balance at Dec. 31, 2020 $ 2,323,939 $ 822 $ 1,317,929 $ 17,763 $ 986,792 $ 771 $ (138) $ 26,708 $ 2,350,647
Balance (in shares) at Dec. 31, 2020   82,185         7    
Increase (Decrease) in Stockholders' Equity                  
Net income 312,310       312,310     8,990 321,300
Other comprehensive loss (17,396)     (17,396)         (17,396)
Stock-based compensation expense 12,889   12,889           12,889
Common stock issued to board members 449   449           449
Common stock issued to board members (in shares)   13              
Issuance of common stock related to share-based awards, net (2,691) $ 3 (2,694)           (2,691)
Issuance of common stock related to share-based awards, net (in shares)   394              
Repurchases of common stock (123,631) $ (35) (58,301)   (65,295)       (123,631)
Repurchases of common stock (in shares)   (3,633)              
Dividends on common stock (29,500)       (29,500)       (29,500)
Deferred compensation plan 2         (20) $ 22   2
Deferred compensation plan (in shares)             (1)    
Net cash distributed to noncontrolling interest               (9,727) (9,727)
Balance at Sep. 30, 2021 2,476,371 $ 790 1,270,272 367 1,204,307 751 $ (116) 25,971 2,502,342
Balance (in shares) at Sep. 30, 2021   78,959         6    
Balance at Jun. 30, 2021 2,470,281 $ 812 1,302,439 7,093 1,159,304 754 $ (121) 26,095 2,496,376
Balance (in shares) at Jun. 30, 2021   81,153         6    
Increase (Decrease) in Stockholders' Equity                  
Net income 92,906       92,906     2,517 95,423
Other comprehensive loss (6,726)     (6,726)         (6,726)
Stock-based compensation expense 4,103   4,103           4,103
Common stock issued to board members 152   152           152
Common stock issued to board members (in shares)   5              
Issuance of common stock related to share-based awards, net (441)   (441)           (441)
Issuance of common stock related to share-based awards, net (in shares)   43              
Repurchases of common stock (74,160) $ (22) (35,981)   (38,157)       (74,160)
Repurchases of common stock (in shares)   (2,242)              
Dividends on common stock (9,746)       (9,746)       (9,746)
Deferred compensation plan 2         (3) $ 5   2
Net cash distributed to noncontrolling interest               (2,641) (2,641)
Balance at Sep. 30, 2021 2,476,371 $ 790 1,270,272 367 1,204,307 751 $ (116) 25,971 2,502,342
Balance (in shares) at Sep. 30, 2021   78,959         6    
Balance at Dec. 31, 2021 2,522,668 $ 790 1,274,446 (10,219) 1,257,014 752 $ (115) 26,535 2,549,203
Balance (in shares) at Dec. 31, 2021   78,965         6    
Increase (Decrease) in Stockholders' Equity                  
Net income 87,578       87,578     5,138 92,716
Other comprehensive loss (109,645)     (109,645)         (109,645)
Stock-based compensation expense 11,553   11,553           11,553
Common stock issued to board members 451   451           451
Common stock issued to board members (in shares)   17              
Issuance of common stock related to share-based awards, net (4,202) $ 4 (4,206)           (4,202)
Issuance of common stock related to share-based awards, net (in shares)   478              
Repurchases of common stock (442,336) $ (148) (238,639)   (203,549)       (442,336)
Repurchases of common stock (in shares)   (14,869)              
Dividends on common stock (33,457)       (33,457)       (33,457)
Deferred compensation plan (799)         (273) $ (526)   (799)
Deferred compensation plan (in shares)             17    
Net cash distributed to noncontrolling interest               (4,601) (4,601)
Balance at Sep. 30, 2022 2,031,811 $ 646 1,043,605 (119,864) 1,107,586 479 $ (641) 27,072 2,058,883
Balance (in shares) at Sep. 30, 2022   64,591         23    
Balance at Jun. 30, 2022 2,029,577 $ 646 1,039,261 (95,279) 1,085,208 695 $ (954) 27,826 2,057,403
Balance (in shares) at Jun. 30, 2022   64,576         34    
Increase (Decrease) in Stockholders' Equity                  
Net income 32,068       32,068     1,186 33,254
Other comprehensive loss (24,585)     (24,585)         (24,585)
Stock-based compensation expense 4,334   4,334           4,334
Common stock issued to board members 146   146           146
Common stock issued to board members (in shares)   6              
Issuance of common stock related to share-based awards, net (136)   (136)           (136)
Issuance of common stock related to share-based awards, net (in shares)   9              
Dividends on common stock (9,690)       (9,690)       (9,690)
Deferred compensation plan 97         (216) $ 313   97
Deferred compensation plan (in shares)             (11)    
Net cash distributed to noncontrolling interest               (1,940) (1,940)
Balance at Sep. 30, 2022 $ 2,031,811 $ 646 $ 1,043,605 $ (119,864) $ 1,107,586 $ 479 $ (641) $ 27,072 $ 2,058,883
Balance (in shares) at Sep. 30, 2022   64,591         23